136Curated trials
Enterprise Evidence Report · NR-REPORT-V2.0
Brazil
Neuroscience Intelligence
Brazil neuroscience evidence report: current clinical, research, institution and source-linked intelligence.
Evidence rank #16 of 50 · Data maturity A · Research score 40.5 · Data confidence 100.0 / 100 · Snapshot 2026-10-12 03:34 UTC.
32Recruiting trials
171Publications
118Institutions
Executive interpretation
Brazil ranks #16 in the current NeuroRisk evidence-ranked market layer. This ranking summarizes indexed clinical, publication and institution evidence; it is not a probability of commercial success and not an investment recommendation.
Methodology status
Methodology NR-REPORT-V2.0. No synthetic ML confidence is presented as scientific probability. Counts and source links below are tied to the generation snapshot.
Methodology →Leading sponsors
Merck Sharp & Dohme LLC126 recruiting
Hoffmann-La Roche115 recruiting
Hospital de Clinicas de Porto Alegre80 recruiting
University of Sao Paulo80 recruiting
Universidade Federal de Pernambuco71 recruiting
Federal University of Rio Grande do Sul60 recruiting
Federal University of Paraíba61 recruiting
University of Sao Paulo General Hospital61 recruiting
GlaxoSmithKline30 recruiting
Federal University of Minas Gerais30 recruiting
Disease activity
Parkinsons33trials
Alzheimers16trials
Pain Neuropathy11trials
Adhd10trials
Epilepsy8trials
Depression6trials
Stroke6trials
Autism4trials
Multiple Sclerosis4trials
Schizophrenia4trials
Research institutions
Hospital Moinhos de VentoOpenAlexlinked institution
Universidade UnigranrioOpenAlexlinked institution
Universidade de FortalezaOpenAlexlinked institution
Universidade Federal do Estado do Rio de JaneiroOpenAlexlinked institution
Universidade Federal do MaranhãoOpenAlexlinked institution
Instituto de Física de São CarlosOpenAlexlinked institution
Irmandade da Santa Casa de Misericórdia de São PauloOpenAlexlinked institution
Instituto Dante Pazzanese de CardiologiaOpenAlexlinked institution
Faculdade Evangélica do ParanáOpenAlexlinked institution
Hospital do CoraçãoOpenAlexlinked institution
Clinical evidence trail
NCT07523126EFFECT OF TRANSCUTANEOUS ELECTRONEURO-STIMULATION OF THE VAGUS NERVE ON JOINT PAIN SEQUELAE OF CHIKUNGUNYA FEVER IN THE LOWER LIMBSACTIVE_NOT_RECRUITING
NCT07216703A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)RECRUITING
NCT07174310A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseaseRECRUITING
NCT07170150A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's DiseaseRECRUITING
NCT07011732A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)RECRUITING
NCT07010471A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of RelutrigineACTIVE_NOT_RECRUITING
NCT06966700A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RECRUITING
NCT06952504A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RECRUITING
Research evidence trail
PUBMEDTactile stimulation modulates withdrawal-related behaviors and brain molecular parameters in male offspring following perinatal morphine exposure.2026-12-15
PUBMEDCardiorespiratory fitness in people with bipolar disorder: A systematic review and meta-analysis.2026-12-15
PUBMEDCircadian misalignment in healthy young adults influences the variability of inhibitory performance modeled by the horse race model.2026-12-01
PUBMEDInfralimbic cortex neurostimulation attenuates nociceptive and affective manifestations in a reserpine-induced fibromyalgia model.2026-12-01
PUBMEDPooled prevalence of anxiety and depressive symptoms among adults with type 2 diabetes: a systematic review and meta-analysis.2026-12-01
PUBMEDPredicting longitudinal post-traumatic stress disorder symptoms using psychological measures and heart rate variability: a machine-learning approach.2026-12-01
PUBMEDComment: Painful tic convulsif: Dual neurovascular compression within the spectrum of cranial nerve hyperactive dysfunction syndromes.2026-12-01
PUBMEDRedox modulation contributes to the antidepressant-like and neuroprotective effects of 7-chloro-4-(phenylselanyl)quinoline in an Alzheimer's disease model.2026-12-01
PUBMEDHIV expression persists in the cerebrospinal fluid of HIV-associated neurocognitive disorders despite effective ART.2026-12-01
PUBMEDCapillary serum-based spectroscopic signature for multiple sclerosis: A novel diagnostic perspective.2026-12-01
World Bank context
Macro indicators are shown only where a timestamped World Bank source row exists. They are context, not NeuroRisk predictions.
Sources and provenance
ClinicalTrials.gov provides NCT evidence. PubMed/NCBI and OpenAlex provide research metadata. OpenAlex links institutions. World Bank indicators are included only when an explicit source row and year exist. NeuroRisk transformations add normalization, ranking and graph connections.
Limitations
Indexed corpus counts are not guaranteed exhaustive global totals. Scores are comparative decision-support signals. This report is not medical advice, regulatory advice, patent clearance, an investment recommendation or a guarantee of outcome.